Tracking ANIK? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Anika Therapeutics, Inc. (ANIK) short interest & options flow

NASDAQ

Anika Therapeutics delivered a Q1 earnings beat this morning, and the market sold it anyway — a classic "buy the rumour, sell the fact" reaction that puts the focus squarely on what comes next from the FDA. The numbers were genuinely good. Q1 adjusted EPS came in at $0.27, well ahead of the consensus estimate of negative $0.16, with revenue of $29.6 million beating the $28.1…

$13.95+3.56% 1d-31.62% 1w-28.75% 1mClose: 11 Nov 2026

Short interest % of float: Low; Live SI on ORTEX →
Cost to borrow: Low and dropping; Live CTB on ORTEX →
Availability: High; Live availability on ORTEX →

Market cap: $187M
Next earnings: 12 Mar 2027

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Anika Therapeutics, Inc. (ANIK) share price and short interest (% of free float), six months to November 11, 2026

ANIK news and analysis

RSS

No long-form analysis yet for ANIK. Pulse alerts and the live data picture are available on ORTEX.

Open ANIK on ORTEX →

Want the live picture for ANIK?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANIK — free to start on ORTEX.

We value your privacy

ANIK news and analysis

Want the live picture for ANIK?